OCTOBER 12, 2018 – FRIDAY
Time Hall A Hall B Hall C
09:00 – 10:30 S11. A harmonised approach to generating and applying biological variation data S12. Role of Gut microbiota in metabolism and inflammatory bowel diseases
Biological variation, from theory to practice. The projects of EFLM
Sverre Sandberg
Gut microbiota and its relationship with obesity, metabolic syndrome and diabetes
Ahmet Uygun
European Biological Variation Study (EuBIVAS): Sample collections from healthy volunteers from six European Labs for biological variation estimates’ update
Anna Carobene 
Celiac disease antibody testing: New trends in diagnosis, guidelines and new markers
Jurgen Stein  
Biological variation of CBC tests: The effect of turnarround time
Abdurrahman Coskun
Faecal biomarkers in diagnosis and monitoring of inflammatory bowel disease
Murat Toruner
10:30 – 10:45 Coffee Break & Posters
10:45 – 11:30 Plenary Lecture: The Liver: Maestro of metabolism
Nurdan Tozun
11:30 – 12:10

Industry-Sponsored Symposium 

Abbott

INNOVATIVE SOLUTIONS TO ACHIEVE MEASURABLY BETTER
HEALTHCARE PERFORMANCE IN THE CORE LAB

Alinity and the next generation core lab: Data behind measurably better healthcare performance
Nilüfer Bayraktar

Improving lab productivity with existing resources: Test pattern optimization through the power of AlinIQ
Ataman Gokel

12:10 – 13:00 Lunch & Posters
13:00 – 14:30 IATDMCT Symposium S17. Harmonisation of training and continuing professional development in laboratory medicine

Oral Presentations

13:00-13:10 Can Pregnancy Associated Plasma Protein-A be a Diagnostic Marker In Patients with Psoriasis?
Fikret Akyurek
13:10-13:20 Markers Of Oxidative Stress Of Neutrophils In Patients With Toxic Nephropathies
Lyudmila Demidchik
13:20-13:30 Modified Proteins In Blood Of Patients With Drug-Induced Nephropathy
Valentina Lee
13:30-13:40 Сarbonyl Derivatives In Plasma And Erythrocytes Of Pregnant Women With Preeclampsia
Dinara Omertayeva
13:40-13:50 Differences In Serum Levels Of Lysophosphatidic Acid And Orexin/Hypocretin In Normal Weight And Obese Patients, Along The Continuum From Health People To Alzheimer’s Disease.
Antonella Angiolillo 
13:50-14:00 Does Table Salt Help Pass A Drug Test In Urine?
Soycan Mızrak
14:00-14:10 1,25-Dihydroxyvitamin D3 Attenuates Matrix Metalloproteinase Expression By İnhibition Of İnflammatory Process İn Chondrosarcoma Cells
Gamze Avcıoğlu
14:10-14:20 Effect Of Ozone On Colon Anastomoses In A Rat Peritonitis Model
Feyza Yagmur Tekeli
14:20-14:30 Translating Mass Spectrometry-Based Protein Assays And The Challenging Road Ahead: Post-Translationally Modified Proteins As Biomarker Targets For Clinical MS Protein Tests
Dobrin Nedelkov

 

The future of LC-MS/MS in forensic laboratory and clinical toxicology
Katharina Rentsch
Curricula of laboratory medicine in medical schools
Thomas Zima
Therapeutic drug monitoring in transplant patients
Eberhard Wieland
Standardization of education of specialists on medical biochemistry in Turkey
Pinar Tuncel
Therapeutic drug monitoring for anti-hypertensive drugs
Erik van Maarseveen
Education of specialists on laboratory medicine in EU
Matthias Orth
14:30 – 14:45 Coffee Break & Posters
14:45 – 15:25 Industry-Sponsored Symposium 
Snibe

15:25 – 16:25 S18. Strategic role of laboratory management and leadership in clinical outcome S1. The role of clinical laboratories in diagnosis and manegement of cancer

Oral Presentations

15:25-15:35 SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B
Banu Isbilen Basok
15:35-15:45 The Utility Of Immunological Markers In The Diagnosis And Management Of Neurological Disorders
Zaid Aburubaiha

 

The role of laboratory specialist in clinical diagnostic team
Roberto Verna
The role of laboratory in determination and management of anticancer therapies
TBA
Laboratory medicine in the new regulatory and healthcare environment: From essentialism to consequentialism
Fatma Taneli
The impact of flow cytometry in clinical laboratory
Brent L. Wood
16:25 – 16:40 Coffee Break
16:40 – 17:40 S13. Autoimmunity, allergic disorders and immunodeficiency S9. Personalized medicine Oral Presentations
The role of the laboratory in diagnosis and management of autoimmune disease
Joanna Sheldon
The role of laboratory medicine in personalized and precision medicine
Mario Pazzagli 
The role of the laboratory in the diagnosis and management of allergic disease
Ravishankar Sargur
Personalized reference intervals
Yesim Ozarda
17:40 –  18:10 The role of the immunology laboratory in the diagnosis and management of primary immune deficiency
Kimberly Gilmour

*may subject to change